- Investor Relations
- Events & Presentations
- Corporate Governance
- Financial Information
- Stock Information
- Investor FAQs
- Contact Us
| Shareholder Tools: |
Shareholder Briefcase
|
Printed Materials
|
Email Alerts
|
Download Library
|
Glossary
|
RSS News Feeds
|
|
Search Investor Relations: |
STOCK INFORMATION |
|
|---|---|
|
NASDAQ : ACUS
$0.69 - 0.02 |
Jul 3, 2008
1:00 PM ET |
|
Quotes delayed at least 20 minutes. Information provided by TurboFeed. |
|
Investor Relations
| Acusphere, Inc.™ is a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its proprietary porous microparticle technology. We are focused on developing proprietary drugs that can offer significant benefits such as improved safety and efficacy, increased patient compliance, greater ease of use, expanded indications or reduced cost. Our three initial product candidates are in clinical development and are designed to address large unmet clinical needs within cardiology, oncology and asthma. |
|
Recent Releases
|
Jun 30, 2008 Acusphere Announces FDA Acceptance of Imagify(TM) NDA for Detection of Coronary Artery Disease |
|
May 20, 2008 Acusphere, Inc. Reschedules IP Payments |